This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).
Web Desc
Diabetes
joint with Islet Biology
Organizer(s): Juleen R. Zierath, Philippe Froguel, Nancy A. Thornberry and Michael P. Czech
Date: April 12 - 17, 2010
Location: Whistler Conference Centre, Whistler, BC, Canada
Sponsored by Eli Lilly and Company and Hoffmann-La Roche, Inc.
Summary of Meeting:
The increased incidence of Type 2 diabetes mellitus is a growing threat to global health. This chronic and progressive metabolic disease is characterized by insulin resistance and beta cell defects, arising from environmental and genetic factors. Multi-disciplinary approaches that capitalize on genetic, genomic and physiological disciplines are required to gain insight into Type 2 diabetes pathogenesis through an increased understanding of the complicated biology that contributes to the development of insulin resistance and beta cell failure. The meeting will focus on latest advancements in our understanding of the molecular pathogenesis of Type 2 diabetes to accelerate the translation of experimental and clinical discoveries to link phenotype to genotype. Particular emphasis will be placed on 1) epigenetics, genetics and pharmacogenomics of metabolic responses, 2) links between pathways linking obesity, inflammation, and insulin resistance and 3) Type 2 diabetes in children and adolescents. A key goal for the meeting will be to facilitate collaborative interactions between basic and clinical scientists focused on prediction, prevention, and treatment of insulin resistance and diabetes.
Scholarship Deadline: December 14 2009
Discounted Abstract Deadline: December 14 2009
Abstract Deadline: January 15 2010
Discounted Registration Deadline: February 12 2010
We gratefully acknowledge additional support for this conference from:
AdipoGen InternationalALPCO DiagnosticsCEDARLANECovX Research LLC (Pfizer)Educational grant from Lilly USA, LLCHoffmann-La Roche, Inc.Landes BioscienceRigel Pharmaceuticals, Inc.Seahorse Bioscience, Inc.
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

Merck & Co., Inc.

Merck Research Laboratories
We gratefully acknowledge the generous grant for this conference provided by:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Grant No. 1R13DK084688-01
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found